Literature DB >> 17037568

Analysis of the N protein in feline coronavirus strains in Italy.

Mara Battilani1, Ambra Foschi, Alessandra Scagliarini, Sara Ciulli, Santino Prosperi, Luigi Morganti.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17037568      PMCID: PMC7123598          DOI: 10.1007/978-0-387-33012-9_72

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  5 in total

1.  Protection from mouse hepatitis virus type 3-induced acute disease by an anti-nucleoprotein monoclonal antibody. Brief report.

Authors:  J Lecomte; V Cainelli-Gebara; G Mercier; S Mansour; P J Talbot; G Lussier; D Oth
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

2.  A semi-empirical method for prediction of antigenic determinants on protein antigens.

Authors:  A S Kolaskar; P C Tongaonkar
Journal:  FEBS Lett       Date:  1990-12-10       Impact factor: 4.124

3.  Mass spectroscopic characterization of the coronavirus infectious bronchitis virus nucleoprotein and elucidation of the role of phosphorylation in RNA binding by using surface plasmon resonance.

Authors:  Hongying Chen; Andrew Gill; Brian K Dove; Stevan R Emmett; C Fred Kemp; Mark A Ritchie; Michael Dee; Julian A Hiscox
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

4.  Prediction of major histocompatibility complex binding regions of protein antigens by sequence pattern analysis.

Authors:  A Sette; S Buus; E Appella; J A Smith; R Chesnut; C Miles; S M Colon; H M Grey
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

5.  Vaccine efficacy of a cell lysate with recombinant baculovirus-expressed feline infectious peritonitis (FIP) virus nucleocapsid protein against progression of FIP.

Authors:  Tsutomu Hohdatsu; Hiroshi Yamato; Tasuku Ohkawa; Miyuki Kaneko; Kenji Motokawa; Hajime Kusuhara; Takashi Kaneshima; Setsuo Arai; Hiroyuki Koyama
Journal:  Vet Microbiol       Date:  2003-12-02       Impact factor: 3.293

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.